Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy

NCT02527213 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company decision -terminated on 30 October 2015

Conditions

Calciphylaxis
Calcific Uremic Arteriolopathy

Interventions

DRUG: Sodium thiosulfate
DRUG: Placebo

Sponsor

American Regent, Inc.